NDC 51660-074 – Guaifenesin and Pseudoephedrine HCl

Guaifenesin 600 mg/1; Pseudoephedrine Hydrochloride 60 mg/1 · Tablet, Extended Release · Oral

Human Otc Drug

Product NDC51660-074

Product details

Brand name
Guaifenesin and Pseudoephedrine HCl
Generic name
Guaifenesin and Pseudoephedrine HCl
Labeler
Ohm Laboratories, Inc.
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA212542
Marketed since
April 1, 2021
Listing expires
December 31, 2026
Pharmacologic class
Expectorant; alpha-Adrenergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Guaifenesin and Pseudoephedrine HCl →

Package NDC codes (1)

Package NDCDescriptionSince
51660-074-181 BLISTER PACK in 1 CARTON (51660-074-18) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACKApr 1, 2021

Other Guaifenesin and Pseudoephedrine HCl products